Zealand Pharma

2024 - 6 - 21

Fantastisk Nyhed: Zealand Pharma Boomer på Børsen med Vægttabsmedicin

aktiemarked - biotekindustrien - kliniske forsøg - vægttabsmedicin - Zealand Pharma

Zealand Pharma oplever eksplosiv vækst på børsen efter positive resultater med vægttabsmedicin! 💊💰 #ZealandPharma #Vægttab #Børsen

Zealand Pharma, et dansk biotekselskab, har for nylig oplevet en markant stigning i deres aktiekurs på børsen. Den seneste udvikling kommer efter virksomhedens positive resultater med en ny vægttabsmedicin, som kunne revolutionere markedet. Zealand Pharma blev belønnet med en stigning på mere end 23% efter offentliggørelsen af lovende resultater fra kliniske forsøg, der viser en gennemsnitlig vægtreduktion på imponerende 8.6% over en 16-ugers periode.

Virksomheden præsenterede petrelintide som en potentiel game-changer inden for vægtstyring og hævdede, at den kan være rygraden i behandlingen på grund af dens effektivitet, der minder om GLP-1 uden de tilhørende bivirkninger. Dette har skabt stor spænding i branchen, da markedet ser frem til et alternativ til eksisterende vægttabsmedicin som Ozempic og Wegovy.

Det imponerende spring i aktiekursen tiltrak investorer, og Zealand Pharma blev genstand for stor opmærksomhed på børsen. Virksomhedens ambition om at levere en bedre patientoplevelse med deres nye vægttabsmedicin har sat dem på kortet som en vigtig spiller i biotekindustrien.

Zealand Pharma's positive resultater med petrelintide har positioneret dem som en markant konkurrent til eksisterende vægttabsmedicin på markedet. Deres fokus på patientoplevelsen og effektiviteten af produktet har skabt stor forventning i branchen, og investorer følger nøje med i virksomhedens videre udvikling.

Europe open: Stocks weaker amid UK data; Zealand Pharma soars (ShareCast)

European stocks were weaker at the open on Friday as investors digested data from the UK that showed a rise in retail sales last month, but also government ...

Post cover
Image courtesy of "NBC New York"

Weight loss drug contender Zealand Pharma jumps 23% on trial ... (NBC New York)

The Danish company is testing a rival to drugs such as Ozempic and Wegovy which it says may deliver a “better patient experience.”

Zealand Pharma shares surge after positive results of weight-loss ... (Morningstar.com)

By Barbara Kollmeyer. Shares of Zealand Pharma soared on Friday after the Danish biotech company reported positive results from a trial of its experimental ...

Post cover
Image courtesy of "MedWatch"

Zealand Pharma reports positive top-line results with weight loss ... (MedWatch)

Patients in the study showed an average weight loss of 8.6 percent with a high weekly dose of petrelintide over a 16-week period.

Zealand Pharma hits record high on positive data from weight loss ... (XM)

... ** Shares in Zealand Pharma ZELA.CO jump more than 23%, touching a record high of DKK 824.50, after the Danish drugmaker posted positive topline data ...

Post cover
Image courtesy of "FierceBiotech"

Zealand pitches backbone obesity drug after seeing phase 1b data (FierceBiotech)

Zealand said petrelintide can be “the backbone of therapy for weight management” because it may provide GLP-1-like efficacy without the side effects.

Post cover
Image courtesy of "MarketWatch"

Zealand Pharma shares surge after trial of weight-loss drug trial (MarketWatch)

Shares of Zealand Pharma soared on Friday after the Danish biotech company reported positive results from a trial of its experimental weight-loss injection, ...

Post cover
Image courtesy of "Investing.com Australia"

Zealand Pharma soars after positive trial results from weight loss drug (Investing.com Australia)

US stock futures drift lower; Nvidia loses most valuable titl.

Zealand Pharma shares soar on obesity results (marketscreener.com)

Zealand Pharma's share price soared on the Copenhagen Stock Exchange on Friday, following the biotech company's announcement of positive results from a ...

Post cover
Image courtesy of "Clinical Trials Arena"

Zealand Pharma says weight loss drug could be comparable to ... (Clinical Trials Arena)

Zealand Pharma believes its weight loss drug petrelintide could be comparable to glucagon like peptide-1 receptor agonists (GLP1-RAs) while providing a ...

Post cover
Image courtesy of "Forbes"

Zealand Pharma Shares Jump 17% After Positive Trial Results For ... (Forbes)

The Danish pharmaceutical firm said its new weight loss drug could compare to Ozempic, Wegovy and other GLP-1 drugs.

Zealand Pharma soars after positive trial results from weight loss drug (Yahoo Finance)

Zealand Pharma said late Thursday that a course of 16 weekly high doses of long-acting amylin analog petrelintide reduced body weight by up to 8.6% on ...

Post cover
Image courtesy of "Yahoo Finance"

Zealand Pharma surges on weight-loss drug trial results (Yahoo Finance)

Shares of Denmark's Zealand Pharma (ZEAL.CO) are surging after an early-stage study of its weight-loss drug produced positive results.

Post cover
Image courtesy of "CNBC"

Weight loss drug contender Zealand Pharma jumps 18% on trial ... (CNBC)

The Danish company is testing a rival to drugs such as Ozempic and Wegovy that it says may deliver a "better patient experience."

Post cover
Image courtesy of "Quartz"

An Ozempic alternative helps people lose weight without as many ... (Quartz)

Zealand Pharma surged 23% after it announced positive clinical trial results for its experimental weight loss drug petrelintide.

Post cover
Image courtesy of "Defenseworld.net"

Reviewing Taylor Wimpey (OTCMKTS:TWODY) and Zealand ... (Defenseworld.net)

Read Reviewing Taylor Wimpey (OTCMKTS:TWODY) and Zealand Pharma A/S (OTCMKTS:ZLDPF) at Defense World.

Explore the last week